Callitas Health Inc. Aktie Deutsche Boerse AG
Aktien
A2GSU1
CA13125C1068
T3F3
Biotechnologie
Umsatz 2018 | 0.75 0.7 0.67 | Umsatz 2019 | 0.71 0.66 0.63 | Marktwert | 3.53 Mio. 3.29 Mio. 3.14 Mio. |
---|---|---|---|---|---|
Nettoergebnis 2018 | -5 Mio. -4.67 Mio. -4.45 Mio. | Nettoergebnis 2019 | -1 Mio. -934’361 -889’620 | EV / Sales 2018 | 4’852’616 x |
Nettoschuld 2018 | 318’990 298’052 283’780 | Nettoschuld 2019 | 847’693 792’051 754’125 | EV / Sales 2019 | 6’168’166 x |
KGV 2018 |
-0.6
x | KGV 2019 |
-1.97
x | Beschäftigte | - |
Rendite 2018 * |
-
| Rendite 2019 |
-
| Streubesitz | 72.04% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | - | 03.01.18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01.12.14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
% 1. Jan. | Kap. | |
---|---|---|
+40.80% | 55.66 Mrd. | |
-8.05% | 38.98 Mrd. | |
+35.79% | 38.8 Mrd. | |
-8.98% | 27.32 Mrd. | |
+10.69% | 26.29 Mrd. | |
-16.21% | 20.25 Mrd. | |
+31.00% | 12.76 Mrd. | |
+28.51% | 12.18 Mrd. | |
-1.67% | 12.12 Mrd. |